Status:
COMPLETED
Micro-RNA (miR) Expression in Upper Gastrointestinal Mucosal Tissue
Lead Sponsor:
Mayo Clinic
Conditions:
Barrett's Esophagus
Esophageal Adenocarcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This is a laboratory-based, exploratory study using tissue obtained from our clinical practice. The purpose of this study is to confirm our ability to characterize miR expression in various tissues (p...
Detailed Description
The incidence of esophageal adenocarcinoma has increased dramatically over the past three decades. These adenocarcinomas usually arise from columnar lined epithelium of the esophagus known as Barrett'...
Eligibility Criteria
Inclusion
- willingness to give consent
- normal gross appearance of the esophagus, stomach and duodenum
Exclusion
- contraindication to mucosal biopsy
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00909350
Start Date
April 1 2008
End Date
November 1 2008
Last Update
February 12 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Jacksonville, Florida, United States, 32224